Regulation of Cortisol in Patients Undergoing Total Joint Arthoplasty.
cortisol
osteoarthritis
regulation
surgery
total joint arthroplasty
Journal
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
ISSN: 1938-2723
Titre abrégé: Clin Appl Thromb Hemost
Pays: United States
ID NLM: 9508125
Informations de publication
Date de publication:
Historique:
entrez:
18
5
2021
pubmed:
19
5
2021
medline:
20
11
2021
Statut:
ppublish
Résumé
Osteoarthritis is a condition in which joint cartilage and bone degenerate progressively over time. Total joint arthroplasty is a definitive treatment. Cortisol is a hormone that is associated with pain and inflammation. This study aims to investigate the cortisol levels in patients undergoing total joint arthroplasty. Plasma samples were collected from 71 total joint arthroplasty (TJA) patients at baseline (pre-surgery), 24 hours post-operation, and 5 days post-operation. Cortisol levels were measured in each sample using a commercially available ELISA kit. All results were compiled as group means ± SD. The plasma cortisol level at baseline were 218.5 ± 12 ng/mL. The 24-hour post-surgical samples showed a marked increase in cortisol levels 240.7 ± 15 ng/mL. The blood samples drawn at the 5th day after surgery showed a downward trend (74 ± 12 ng/mL). At 5 days post-operation, cortisol levels were significantly lower than at baseline or 24 hours post-operation. These results point to the fact that prior to surgery, the patient's emotional stress contributes to increased serum cortisol levels. The higher level of cortisol persists at 24 hours post-operation due to inflammation from the procedure. This data also suggests that at 5 days post-operation, the inflammatory response from the surgery and emotional stress subside, resulting in a near normalization of the cortisol levels. Cortisol is a hormone that plays a major role in the body's response to surgery. The relevance between cortisol and different points in the surgical timeline has the potential to prognosticate and improve recovery measures.
Identifiants
pubmed: 34000837
doi: 10.1177/1076029621987614
pmc: PMC8135205
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1076029621987614Subventions
Organisme : NIAID NIH HHS
ID : T35 AI125220
Pays : United States
Organisme : NHLBI NIH HHS
ID : T35 HL120835
Pays : United States
Références
J Surg Res. 1991 Feb;50(2):129-34
pubmed: 1899278
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Semin Arthritis Rheum. 1997 Aug;27(1):44-7
pubmed: 9287389
Clin Endocrinol (Oxf). 2018 Nov;89(5):554-567
pubmed: 30047158
Crit Care. 2013 Mar 01;17(2):R38
pubmed: 23452669
Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):112-117
pubmed: 31621559
Best Pract Res Clin Rheumatol. 2014 Feb;28(1):5-15
pubmed: 24792942
World Neurosurg. 2019 Sep;129:e436-e443
pubmed: 31150852
J Clin Endocrinol Metab. 1987 May;64(5):986-94
pubmed: 3031124
Phys Ther. 2014 Dec;94(12):1816-25
pubmed: 25035267
BMB Rep. 2015 Apr;48(4):209-16
pubmed: 25560699
Sleep Med. 2007 Sep;8(6):613-22
pubmed: 17383933
PLoS One. 2018 Jun 21;13(6):e0199226
pubmed: 29927991
BMC Musculoskelet Disord. 2017 Dec 19;18(1):541
pubmed: 29258488
Clin Endocrinol (Oxf). 2017 Nov;87(5):451-458
pubmed: 28758231
J Endocr Soc. 2018 Sep 20;2(12):1338-1344
pubmed: 30511036